Medicalgorithmics S.A.

Medicalgorithmics S.A. is a Warsaw-based, publicly listed (GPW) medical technology company founded in 2005, specializing in AI-powered, noninvasive cardiac diagnostic solutions. The company develops and manufactures a comprehensive suite of ECG monitoring devices and cloud-based software platforms that leverage advanced artificial intelligence to detect, classify, and analyze cardiac arrhythmias. Key product offerings include PocketECG (full-disclosure mobile cardiac telemetry with rich diagnostic reporting), Kardiobeat.ai (wearable 24–18 day Holter monitor with AI-driven analysis), DeepRhythm Platform (DRP) – a hardware-agnostic cloud ECG platform with FDA clearance and Health Canada licensing – DeepRhythmAI (DRAI) for rapid arrhythmia detection across third-party devices, and Virtual Cardiac Stress Test (VCAST), an advanced CT-based diagnostic tool for coronary artery assessment. All core products carry FDA 510(k) clearance, EU MDR certification, and Health Canada approval. The company serves cardiologists, healthcare systems, and clinical research organizations across North America, Europe, and Asia-Pacific, with an extensive annotated heartbeat library supporting over 100 arrhythmia types. Medicalgorithmics also provides R&D services, clinical trial support, and scientific research partnerships focused on cardiovascular disease diagnosis.